Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Vaccination approach to anti-angiogenic treatment of cancer.
Biochim Biophys Acta. 2015 Apr;1855(2):155-71. doi: 10.1016/j.bbcan.2015.01.005. Epub 2015 Jan 30.
Biochim Biophys Acta. 2015.
PMID: 25641676
Review.
A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer.
Wentink MQ, Broxterman HJ, Lam SW, Boven E, Walraven M, Griffioen AW, Pili R, van der Vliet HJ, de Gruijl TD, Verheul HM.
Wentink MQ, et al.
Br J Cancer. 2016 Oct 11;115(8):940-948. doi: 10.1038/bjc.2016.275. Epub 2016 Aug 30.
Br J Cancer. 2016.
PMID: 27575850
Free PMC article.
Item in Clipboard
Reply to Marchiò et al.: Antitumor immune regulation by angiostatic therapy.
Wentink MQ, Huijbers EJM, Timmerman P, Griffioen AW.
Wentink MQ, et al.
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):E3166-E3167. doi: 10.1073/pnas.1703074114. Epub 2017 Apr 11.
Proc Natl Acad Sci U S A. 2017.
PMID: 28400520
Free PMC article.
No abstract available.
Item in Clipboard
Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.
Wentink MQ, Hackeng TM, Tabruyn SP, Puijk WC, Schwamborn K, Altschuh D, Meloen RH, Schuurman T, Griffioen AW, Timmerman P.
Wentink MQ, et al.
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12532-12537. doi: 10.1073/pnas.1610258113. Epub 2016 Oct 17.
Proc Natl Acad Sci U S A. 2016.
PMID: 27791128
Free PMC article.
Item in Clipboard
A safety and immunogenicity study of immunization with hVEGF26-104/RFASE in cynomolgus monkeys.
Wentink MQ, Verheul HMW, Griffioen AW, Schafer KA, McPherson S, Early RJ, van der Vliet HJ, de Gruijl TD.
Wentink MQ, et al.
Vaccine. 2018 Apr 5;36(15):2025-2032. doi: 10.1016/j.vaccine.2018.02.066. Epub 2018 Mar 5.
Vaccine. 2018.
PMID: 29519591
Free article.
Item in Clipboard
A Phase I Open-Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26-104/RFASE in Patients with Advanced Solid Malignancies.
Goedegebuure RSA, Wentink MQ, van der Vliet HJ, Timmerman P, Griffioen AW, de Gruijl TD, Verheul HMW.
Goedegebuure RSA, et al. Among authors: wentink mq.
Oncologist. 2021 Feb;26(2):e218-e229. doi: 10.1002/onco.13576. Epub 2020 Nov 19.
Oncologist. 2021.
PMID: 33105058
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma.
Wentink MQ, Verheul HMW, Pal SK, George S, Voortman J, Danchaivijitr P, Adelaiye R, Poslinski D, Groman A, Hutson A, Pili R.
Wentink MQ, et al.
Clin Genitourin Cancer. 2017 Jul 14:S1558-7673(17)30201-X. doi: 10.1016/j.clgc.2017.07.004. Online ahead of print.
Clin Genitourin Cancer. 2017.
PMID: 28781191
Item in Clipboard
Incidence and histological features of colorectal cancer in the Northern Cape Province, South Africa.
Wentink MQ, Räkers M, Stupart DA, Algar U, Ramesar R, Goldberg PA.
Wentink MQ, et al.
S Afr J Surg. 2010 Nov;48(4):109-13.
S Afr J Surg. 2010.
PMID: 21542398
Item in Clipboard
Cite
Cite